Kala Bio (KALA) Operating Leases (2021 - 2025)

Kala Bio has disclosed Operating Leases across 4 years of filings, most recently posting $1.1 million for Q3 2025.

• In Q3 2025, Operating Leases fell 27.42% year-over-year to $1.1 million; the TTM figure through Sep 2025 stood at $1.1 million (down 27.42% YoY), while the FY2024 annual figure was $1.4 million, down 20.29% from the prior year.
• Operating Leases came in at $1.1 million for Q3 2025 at Kala Bio, down from $1.2 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $1.9 million in Q3 2023 to a low of $548000.0 in Q4 2021.
• Average Operating Leases over 4 years is $1.4 million, with a median of $1.5 million recorded in 2024.
• Year-over-year, Operating Leases dropped 18.51% in 2024 and fell 27.42% in 2025.
• Over 4 years, Operating Leases stood at $548000.0 in 2021, then soared by 228.28% to $1.8 million in 2023, then decreased by 20.29% to $1.4 million in 2024, then decreased by 22.45% to $1.1 million in 2025.
• Per Business Quant data, the three most recent Operating Leases figures were $1.1 million in Q3 2025, $1.2 million in Q2 2025, and $1.3 million in Q1 2025.